Biotech Steals The Show Following Pre-Clinical Data Announcement
27 Março 2024 - 4:35PM
AllPennyStocks.com
A California-based biotech company stirred
things up on Wednesday after it was announced the publication of
preclinical data on its lead clinical compound, LB-100.
To read the full story on AllPennyStocks.com, click
here.
Lixte Biotechnology (NASDAQ:LIXT)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Lixte Biotechnology (NASDAQ:LIXT)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024